Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
Prescription drug companies and trade groups shelled out millions of dollars to lobby Congress as it considered legislation aimed at reining in skyrocketing drug prices, according to new lobbying disclosure reports. The Pharmaceutical Research and Manufacturers of America (PhRMA) — the trade group representing branded drug companies — spent $6.2 million on lobbying in the third quarter of 2019, which ran from July through the end of September.
WASHINGTON — Democratic lawmakers in recent weeks have begun to advance an argument long seen as something of a third rail in U.S. politics: that slightly less biomedical innovation might be worth a dramatic reduction in drug prices. The surprising candor has come amid pushback to House Speaker Nancy Pelosi’s high-profile drug pricing bill, which the trade group PhRMA this month said represented “nuclear winter” for the development of new medicines.
People buying insurance through Covered California might see lower prices this time around, following changes in Gov. Gavin Newsom’s most recent state budget. Enrollment for the state’s health benefit exchange begins Oct. 15. Certain low-income Californians are already eligible for subsidies from the federal government to help pay their premiums, but this year there are new state dollars to help low and middle income residents.
Enrollment in Medicaid in 2019 declined by nearly 2% and is expected to be largely flat, with an increase of 0.8%, next year due in part to the economy and stringent eligibility rules, according to a new survey.
Change is coming for Nevadans who purchase health insurance through the online marketplace available to those who aren’t insured through their employers, Medicare or Medicaid.
As the presidential candidates spar over health reform proposals, a new analysis of eight different Democratic reform models found they would cover from 11 million to 35 million more Americans while costing the federal government from $590 billion to $34 trillion over 10 years.
House Democratic leaders are adjusting their signature bill to lower drug prices in an effort to address progressive concerns that a previous version of it was not strong enough.
A day after they sparred in a Democratic presidential debate, Mr. Biden aimed more criticism at Ms. Warren, who has joined him as a front-runner.
Drugmakers fought hard against California’s groundbreaking drug price transparency law, passed in 2017. Now, state health officials have released their first report on the price hikes those drug companies sought to shield.
If you tuned in for the first five nights of the Democratic presidential debates, you might think “Medicare for All” and providing universal care are the only health care ideas Democrats have.